Columbia, MD, United States of America

Ngeh J Toyang

This inventor holds 9 USPTO granted patents and 8 published patent applications. Top assignees: Educational & Scientific LLC, Flavocure Biotech, Inc., University System of Maryland. Active years: 2017-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ngeh J Toyang. Retrieved from https://idiyas.com/inventor/ngeh-j-toyang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 44.4

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Ngeh J Toyang in Cannabis-Based Therapeutics

Introduction

Ngeh J Toyang, an inventor based in Columbia, MD, has made significant contributions to the field of therapeutics, particularly in relation to cannabis-derived compounds. With a total of 9 patents to his name, Toyang's work focuses primarily on developing innovative pharmaceutical compositions targeting various cancers and viral infections, showcasing the potential of flavonoids and cannabinoids in modern medicine.

Latest Patents

Among Toyang's noteworthy inventions is a pharmaceutical composition that incorporates cannabis flavonoid derivatives aimed at targeting kinases, sirtuins, and oncogenic agents for cancer treatment. This patent describes a flavonoid-based composition that includes selections from a diverse group of compounds such as Apigenin, Cannflavin A, Cannflavin B, Cannflavin C, Chrysoeriol, and others. The invention highlights how these flavonoids can effectively prevent and treat a range of cancers including brain, breast, colon, renal, liver, lung, pancreatic, prostate, leukemia, melanoma, and others whereby the oncogenic factors are inhibited.

Additionally, Toyang patented a cannabinoid-based pharmaceutical composition aimed at addressing hepatitis C infection. This composition utilizes cannabidiol or its pharmaceutically acceptable salts, providing a method to prevent and treat pathogenic viruses associated with hepatic conditions, particularly hepatitis B and C.

Career Highlights

Throughout his career, Ngeh J Toyang has collaborated with prestigious institutions, contributing his scientific expertise to major projects. Notably, he has been associated with the University of Maryland, Baltimore, leveraging its research capabilities to further his innovative ideas and develop his patents.

Collaborations

Throughout his journey, Toyang has worked alongside esteemed colleagues such as Henry Lowe and Joseph Bryant. These collaborations have enriched his research and helped in nurturing a dynamic exchange of ideas, which often leads to groundbreaking innovations in the field of medicinal applications of cannabis-derived compounds.

Conclusion

Ngeh J Toyang stands out as a prominent figure in the realm of pharmaceutical innovation, particularly encompassing the therapeutic use of cannabinoids and flavonoids. His continued research and patents promise to pave the way for new treatments for challenging health conditions, demonstrating the profound impact that inventive minds can have in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…